Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin

Abstract

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1016/i.jvir.2019.04.023

Publication Info

Celik, Haydar, Paul Wakim, William F Pritchard, Meryll Castro, Shelby Leonard, John W Karanian, Mark W Dewhirst, Riccardo Lencioni, et al. (2019). Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 30(12). pp. 1908–1914. 10.1016/i.jvir.2019.04.023 Retrieved from https://hdl.handle.net/10161/20611.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.